v3.26.1
Subsequent Events
6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 16 – SUBSEQUENT EVENTS

 

In accordance with ASC 855 management has performed an evaluation of subsequent events through the date that the unaudited financial statements were issued and has determined that it has the following material subsequent events to disclose in these unaudited financial statements.

 

On August 7, 2026, the Company issued 1,170,000 shares of common stock to a third party for AI consulting services. The shares were valued at $0.3059, the closing stock price on the date of grant, for total non-cash expense of $357,903.

 

On August 7, 2026, the Company issued 1,170,000 shares of common stock to a third party for consulting services. The shares were valued at $0.3059, the closing stock price on the date of grant, for total non-cash expense of $357,903.

 

On August 7, 2026, the Company issued 1,250,000 shares of common stock to a third party for AI consulting services. The shares were valued at $0.3059, the closing stock price on the date of grant, for total non-cash expense of $382,375.

 

On August 7, 2026, the Company issued 1,170,000 shares of common stock to a third party for consulting services. The shares were valued at $0.3059, the closing stock price on the date of grant, for total non-cash expense of $357,903.

 

On August 7, 2026, the Company issued 1,170,000 shares of common stock to a third party to be used for the settlement of accounts payable. The shares were valued at $0.3059, the closing stock price on the date of grant, for total value of $357,903.

 

On August 7, 2026, the Company issued 1,170,000 shares of common stock to a service provider for the settlement of accounts payable. The shares were valued at $0.3059, the closing stock price on the date of grant, for total value of $357,903.

 

On August 7, 2026, the Company issued 1,170,000 shares of common stock to a third party to be used for the settlement of accounts payable. The shares were valued at $0.3059, the closing stock price on the date of grant, for total value of $357,903.

 

All shares of common stock issued pursuant to these transactions were issued in reliance upon Section 4(a)(2) of the Securities Act and are restricted securities under Rule 144.